Paper in rolls, wallpaper, other papers and documents -- Note: Including toilet paper and paper towels.Papiers en rouleaux, papiers peints, autres papiers et documents -- Note: Y compris le papier hygiénique et les essuie-mains en papier.

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 7

BrownBrun

29 . 1 . 4

BlueBleu

Trademark usage description

anti-infectives; anti-inflammatories; antibiotics; antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases Read More

Classification Information

Class [005]
Anti-infectives; anti-inflammatories; antibiotics; antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for use in dermatology namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system; pharmaceutical preparations for the prevention and treatment of disease and disorder of the metabolic system, namely diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases, infections and disorders of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the genitourinary system, namely infertility, sexually transmitted disease, inflammatory pelvic disease; pharmaceutical preparations for use in hematology, namely the treatment of blood disorders; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical products for use in ophthalmology; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification kind code

Mark Details

Serial Number

1869029

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 24^th Feb 2020	Approved
Submitted for opposition 27 on 24^th Feb 2020	Approval Notice Sent
Submitted for opposition 15 on 07^th Nov 2019	Correspondence Created
Submitted for opposition 67 on 11^th Sep 2019	Agent Name Changed
Submitted for opposition 15 on 27^th Jun 2019	Correspondence Created
Submitted for opposition 22 on 30^th Oct 2018	Search Recorded
Submitted for opposition 20 on 30^th Oct 2018	Examiner's First Report
Submitted for opposition 31 on 28^th Nov 2017	Formalized
Submitted for opposition 1 on 22^nd Nov 2017	Created
Submitted for opposition 30 on 21^st Nov 2017	Filed